Annual CFF
-$8.57 M
-$7.99 M-1377.59%
December 31, 2023
Summary
- As of February 7, 2025, MDXG annual cash flow from financing activities is -$8.57 million, with the most recent change of -$7.99 million (-1377.59%) on December 31, 2023.
- During the last 3 years, MDXG annual CFF has fallen by -$70.13 million (-113.92%).
- MDXG annual CFF is now -113.63% below its all-time high of $62.86 million, reached on December 31, 2019.
Performance
MDXG Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$27.00 K
+$386.00 K+107.52%
September 30, 2024
Summary
- As of February 7, 2025, MDXG quarterly cash flow from financing activities is $27.00 thousand, with the most recent change of +$386.00 thousand (+107.52%) on September 30, 2024.
- Over the past year, MDXG quarterly CFF has increased by +$33.49 million (+100.08%).
- MDXG quarterly CFF is now -99.96% below its all-time high of $66.75 million, reached on June 30, 2019.
Performance
MDXG Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
-$42.74 M
-$343.00 K-0.81%
September 30, 2024
Summary
- As of February 7, 2025, MDXG TTM cash flow from financing activities is -$42.74 million, with the most recent change of -$343.00 thousand (-0.81%) on September 30, 2024.
- Over the past year, MDXG TTM CFF has dropped by -$706.00 thousand (-1.68%).
- MDXG TTM CFF is now -165.56% below its all-time high of $65.19 million, reached on June 30, 2019.
Performance
MDXG TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
MDXG Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -1377.6% | +100.1% | -1.7% |
| 3 y3 years | -113.9% | +102.6% | -1954.8% |
| 5 y5 years | +4.1% | +102.4% | -168.0% |
MDXG Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -1377.6% | at low | -92.7% | +100.1% | -9555.5% | at low |
| 5 y | 5-year | -113.6% | at low | -100.0% | +100.1% | -168.0% | at low |
| alltime | all time | -113.6% | +85.8% | -100.0% | +100.1% | -165.6% | +29.4% |
MiMedx Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $27.00 K(-107.5%) | -$42.74 M(+0.8%) |
| Jun 2024 | - | -$359.00 K(-98.9%) | -$42.40 M(+0.9%) |
| Mar 2024 | - | -$33.47 M(+274.4%) | -$42.03 M(+390.5%) |
| Dec 2023 | -$8.57 M(+1377.6%) | -$8.94 M(-2516.2%) | -$8.57 M(-2065.6%) |
| Sep 2023 | - | $370.00 K(+9150.0%) | $436.00 K(+122.4%) |
| Jun 2023 | - | $4000.00(-200.0%) | $196.00 K(-56.6%) |
| Mar 2023 | - | -$4000.00(-106.1%) | $452.00 K(-177.9%) |
| Dec 2022 | -$580.00 K(-82.7%) | $66.00 K(-49.2%) | -$580.00 K(-7.1%) |
| Sep 2022 | - | $130.00 K(-50.0%) | -$624.00 K(-31.0%) |
| Jun 2022 | - | $260.00 K(-125.1%) | -$904.00 K(-56.5%) |
| Mar 2022 | - | -$1.04 M(-4809.1%) | -$2.08 M(-37.9%) |
| Dec 2021 | -$3.35 M(-105.4%) | $22.00 K(-114.7%) | -$3.35 M(-27.4%) |
| Sep 2021 | - | -$150.00 K(-83.6%) | -$4.62 M(-107.4%) |
| Jun 2021 | - | -$916.00 K(-60.3%) | $62.27 M(+1.4%) |
| Mar 2021 | - | -$2.31 M(+85.7%) | $61.43 M(-0.2%) |
| Dec 2020 | $61.56 M(-2.1%) | -$1.24 M(-101.9%) | $61.56 M(-0.2%) |
| Sep 2020 | - | $66.73 M(-3906.8%) | $61.67 M(-1010.2%) |
| Jun 2020 | - | -$1.75 M(-19.5%) | -$6.78 M(-111.0%) |
| Mar 2020 | - | -$2.18 M(+91.3%) | $61.73 M(-1.8%) |
| Dec 2019 | $62.86 M(-803.6%) | -$1.14 M(-33.3%) | $62.86 M(-1.3%) |
| Sep 2019 | - | -$1.71 M(-102.6%) | $63.71 M(-2.3%) |
| Jun 2019 | - | $66.75 M(-6493.5%) | $65.19 M(-3555.0%) |
| Mar 2019 | - | -$1.04 M(+266.3%) | -$1.89 M(-78.9%) |
| Dec 2018 | -$8.93 M(-85.2%) | -$285.00 K(+27.2%) | -$8.93 M(-73.1%) |
| Sep 2018 | - | -$224.00 K(-32.9%) | -$33.23 M(-45.1%) |
| Jun 2018 | - | -$334.00 K(-95.9%) | -$60.58 M(+9.5%) |
| Mar 2018 | - | -$8.09 M(-67.1%) | -$55.34 M(-8.4%) |
| Dec 2017 | -$60.39 M(+640.9%) | -$24.59 M(-10.8%) | -$60.39 M(+72.0%) |
| Sep 2017 | - | -$27.57 M(-662.0%) | -$35.10 M(+148.8%) |
| Jun 2017 | - | $4.91 M(-137.3%) | -$14.11 M(-22.4%) |
| Mar 2017 | - | -$13.14 M(-1982.2%) | -$18.18 M(+123.1%) |
| Dec 2016 | -$8.15 M(-77.5%) | $698.00 K(-110.6%) | -$8.15 M(-70.2%) |
| Sep 2016 | - | -$6.58 M(-889.4%) | -$27.38 M(+11.6%) |
| Jun 2016 | - | $833.00 K(-126.8%) | -$24.54 M(-13.2%) |
| Mar 2016 | - | -$3.11 M(-83.2%) | -$28.28 M(-21.9%) |
| Dec 2015 | -$36.23 M | -$18.54 M(+396.8%) | -$36.23 M(+115.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2015 | - | -$3.73 M(+28.2%) | -$16.80 M(+27.9%) |
| Jun 2015 | - | -$2.91 M(-73.7%) | -$13.14 M(-8.6%) |
| Mar 2015 | - | -$11.05 M(-1342.7%) | -$14.38 M(+570.1%) |
| Dec 2014 | -$2.15 M(-105.3%) | $889.00 K(-1407.4%) | -$2.15 M(-106.2%) |
| Sep 2014 | - | -$68.00 K(-98.4%) | $34.63 M(-3.7%) |
| Jun 2014 | - | -$4.15 M(-450.0%) | $35.98 M(-11.6%) |
| Mar 2014 | - | $1.19 M(-96.8%) | $40.68 M(+0.1%) |
| Dec 2013 | $40.63 M(+514.7%) | $37.67 M(+2846.0%) | $40.63 M(+1167.9%) |
| Sep 2013 | - | $1.28 M(+134.2%) | $3.20 M(-59.5%) |
| Jun 2013 | - | $545.90 K(-52.2%) | $7.92 M(+5.5%) |
| Mar 2013 | - | $1.14 M(+379.8%) | $7.51 M(+13.6%) |
| Dec 2012 | $6.61 M(-34.8%) | $238.10 K(-96.0%) | $6.61 M(-41.6%) |
| Sep 2012 | - | $5.99 M(+4306.0%) | $11.32 M(+98.1%) |
| Jun 2012 | - | $136.00 K(-44.2%) | $5.72 M(-32.6%) |
| Mar 2012 | - | $243.70 K(-95.1%) | $8.48 M(-16.3%) |
| Dec 2011 | $10.14 M(+44.9%) | $4.95 M(+1179.1%) | $10.14 M(+25.3%) |
| Sep 2011 | - | $386.90 K(-86.7%) | $8.09 M(+5.0%) |
| Jun 2011 | - | $2.90 M(+53.1%) | $7.70 M(-3.8%) |
| Mar 2011 | - | $1.90 M(-34.6%) | $8.01 M(+14.4%) |
| Dec 2010 | $7.00 M(-12.0%) | $2.90 M(>+9900.0%) | $7.00 M(+70.8%) |
| Sep 2010 | - | $0.00(-100.0%) | $4.10 M(-6.7%) |
| Jun 2010 | - | $3.21 M(+261.8%) | $4.39 M(-3.0%) |
| Mar 2010 | - | $886.90 K(+200.6%) | $4.53 M(-6.9%) |
| Dec 2009 | $7.95 M(+261.9%) | - | - |
| Sep 2009 | - | $295.00 K(-91.2%) | $4.86 M(-12.3%) |
| Jun 2009 | - | $3.34 M(+537.0%) | $5.54 M(+152.2%) |
| Mar 2009 | - | $525.00 K(-24.7%) | $2.20 M(+31.4%) |
| Mar 2009 | $2.20 M(-42.7%) | - | - |
| Dec 2008 | - | $697.50 K(-28.5%) | $1.67 M(+71.3%) |
| Sep 2008 | - | $975.00 K(>+9900.0%) | $976.50 K(>+9900.0%) |
| Jun 2008 | - | $0.00(-100.0%) | $2500.00(-85.7%) |
| Mar 2008 | $3.84 M(>+9900.0%) | - | - |
| Dec 2007 | $17.50 K(-41.7%) | $1500.00(+50.0%) | $17.50 K(+9.4%) |
| Sep 2007 | - | $1000.00(-93.3%) | $16.00 K(+6.7%) |
| Jun 2007 | - | $15.00 K(>+9900.0%) | $15.00 K(>+9900.0%) |
| Mar 2007 | - | $0.00 | $0.00 |
| Dec 2006 | $30.00 K | - | - |
FAQ
- What is MiMedx annual cash flow from financing activities?
- What is the all time high annual CFF for MiMedx?
- What is MiMedx annual CFF year-on-year change?
- What is MiMedx quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for MiMedx?
- What is MiMedx quarterly CFF year-on-year change?
- What is MiMedx TTM cash flow from financing activities?
- What is the all time high TTM CFF for MiMedx?
- What is MiMedx TTM CFF year-on-year change?
What is MiMedx annual cash flow from financing activities?
The current annual CFF of MDXG is -$8.57 M
What is the all time high annual CFF for MiMedx?
MiMedx all-time high annual cash flow from financing activities is $62.86 M
What is MiMedx annual CFF year-on-year change?
Over the past year, MDXG annual cash flow from financing activities has changed by -$7.99 M (-1377.59%)
What is MiMedx quarterly cash flow from financing activities?
The current quarterly CFF of MDXG is $27.00 K
What is the all time high quarterly CFF for MiMedx?
MiMedx all-time high quarterly cash flow from financing activities is $66.75 M
What is MiMedx quarterly CFF year-on-year change?
Over the past year, MDXG quarterly cash flow from financing activities has changed by +$33.49 M (+100.08%)
What is MiMedx TTM cash flow from financing activities?
The current TTM CFF of MDXG is -$42.74 M
What is the all time high TTM CFF for MiMedx?
MiMedx all-time high TTM cash flow from financing activities is $65.19 M
What is MiMedx TTM CFF year-on-year change?
Over the past year, MDXG TTM cash flow from financing activities has changed by -$706.00 K (-1.68%)